Heribert Schunkert – författare

Apoptosis or programmed cell death is increasingly considered to be a major factor in the development and progression of cardiovascular disease. In patients with heart failure the activation of apoptosis may result in the loss of irreplaceable cardiac myocytes promoting the clinical course of the syndrome. Moreover, in the coronary arteries inflammation and apoptosis may weaken critical structures of the vessel wall leading to plaque rupture and, subsequently, to myocardial infarction. Given these deleterious consequences, it seems almost paradoxical that programmed cell death is an active process that, if initiated under physiological circumstances, is essential for both coordinated tissue growth or destruction of malignant cells. Apoptosis in Cardiac Biology, written by a team of internationally renowned researchers, gives a timely synopsis of basic mechanisms, cellular and structural targets and, finally, clinical implications of programmed cell death in the heart. The expert authors of this volume give concise overviews on general and cell-specific aspects of programmed cell death in cardiac myocytes and fibroblasts, as well as in vascular smooth muscle and endothelial cells. Furthermore, novel therapeutic options arising from the outstanding pathophysiological significance of cardiac apoptosis are presented. This comprehensive review of Apoptosis in Cardiac Biology will be of interest to both clinicians and basic researchers who are active in the fields of cardiology and atherosclerosis.

Apoptosis or programmed cell death is increasingly considered to be a major factor in the development and progression of cardiovascular disease. In patients with heart failure the activation of apoptosis may result in the loss of irreplaceable cardiac myocytes promoting the clinical course of the syndrome. Moreover, in the coronary arteries inflammation and apoptosis may weaken critical structures of the vessel wall leading to plaque rupture and, subsequently, to myocardial infarction. Given these deleterious consequences, it seems almost paradoxical that programmed cell death is an active process that, if initiated under physiological circumstances, is essential for both coordinated tissue growth or destruction of malignant cells. Apoptosis in Cardiac Biology, written by a team of internationally renowned researchers, gives a timely synopsis of basic mechanisms, cellular and structural targets and, finally, clinical implications of programmed cell death in the heart. The expert authors of this volume give concise overviews on general and cell-specific aspects of programmed cell death in cardiac myocytes and fibroblasts, as well as in vascular smooth muscle and endothelial cells. Furthermore, novel therapeutic options arising from the outstanding pathophysiological significance of cardiac apoptosis are presented. This comprehensive review of Apoptosis in Cardiac Biology will be of interest to both clinicians and basic researchers who are active in the fields of cardiology and atherosclerosis.

Apoptosis or programmed cell death is increasingly considered to be a major factor in the development and progression of cardiovascular disease. In patients with heart failure the activation of apoptosis may result in the loss of irreplaceable cardiac myocytes promoting the clinical course of the syndrome. Moreover, in the coronary arteries inflammation and apoptosis may weaken critical structures of the vessel wall leading to plaque rupture and, subsequently, to myocardial infarction. Given these deleterious consequences, it seems almost paradoxical that programmed cell death is an active process that, if initiated under physiological circumstances, is essential for both coordinated tissue growth or destruction of malignant cells. Apoptosis in Cardiac Biology, written by a team of internationally renowned researchers, gives a timely synopsis of basic mechanisms, cellular and structural targets and, finally, clinical implications of programmed cell death in the heart. The expert authors of this volume give concise overviews on general and cell-specific aspects of programmed cell death in cardiac myocytes and fibroblasts, as well as in vascular smooth muscle and endothelial cells. Furthermore, novel therapeutic options arising from the outstanding pathophysiological significance of cardiac apoptosis are presented. This comprehensive review of Apoptosis in Cardiac Biology will be of interest to both clinicians and basic researchers who are active in the fields of cardiology and atherosclerosis.

Die Behandlung von Patienten mit chronischer Herzinsuffizienz ist eine Herausforderung für jeden Arzt!Mit dem pathophysiologischen Wissen sind auch die Therapiemöglichkeiten im letzten Jahrzehnt enorm gewachsen. Sie ermöglichen zunehmend ein rational begründetes Vorgehen, das auf die individuelle Situation des Patienten abgestimmt ist.Lassen Sie das aktuelle Wissen zu Diagnostik und Therapie der Herzinsuffizienz auch ihren Patienten zugute kommen - alle Informationen, die Sie benötigen, finden Sie in übersichtlicher und handlungsorientierter Darstellung in diesem Buch.

Die Behandlung der koronaren Herzerkrankung stellt eine gemeinsame Herausforderung für Haus-, Fach- und Klinikärzte dar. In diesem Buch werden daher übergreifend für den ambulanten und stationären Bereich die Prinzipien in Diagnostik und Therapie der KHK beleuchtet. Insbesondere werden detaillierte Entscheidungshilfen gegeben, bei welcher Befundkonstellation nicht-invasive Untersuchungen oder eine Koronarangiographie indiziert sind. Neben konservativen Präventions- und Therapiemaßnahmen werden ausführlich und vergleichend die interventionellen und herzchirurgischen Therapiemöglichkeiten diskutiert. So soll das Buch als "interdisziplinärer" Ratgeber für Allgemeinmediziner, Internisten, Kardiologen und Herzchirurgen einen Beitrag zur optimalen und ökonomisch vertretbaren Betreuung von Patienten mit koronarer Herzkrankheit in Praxis und Klinik liefern.